HRS9531 injection;Placebo for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Apr 2026: Trial registered, NCT07559136
  2. 12 Jun 2026: Trial started, NCT07559136

The trials

NCT07559136: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity

State
Under way
Phase
Phase 1
People
48 taking part
Started
12 Jun 2026
Primary completion
Feb 2027
Arms
Treatment group A: HRS9531 injection or Placebo, Treatment group B: HRS9531 injection or Placebo, Treatment group C: HRS9531 injection or Placebo
Results
None posted
  1. 30 Apr 2026: Trial registered
  2. 12 Jun 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.